{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:57:17Z","timestamp":1788875837934,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T00:00:00Z","timestamp":1615680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>TNF receptor-1-associated periodic syndrome (TRAPS) is a rare autosomal dominant autoinflammatory disorder associated with mutations in the TNF receptor super family 1\u2009A (TNFRSF1A) gene. AA amyloidosis (AA) is the most severe complication of TRAPS. To study the occurrence and prognosis of AA in TRAPS, we conducted a retrospective study of all French cases and a systematic literature review.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This case series includes TRAPS patients followed by our centre from 2000 to 2020 presenting with histologically confirmed AA. We conducted a systematic literature review on the PubMed and EMBASE databases for articles published up to February 2021 following the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines and using the keywords: amyloidoisis, amyloid, TNF receptor-associated periodic syndrome, TNF receptor-associated periodic syndrome, tumor necrosis factor receptor-associated periodic syndrome, TRAPS, TNFRSF1A, familial hibernian fever and hibernian familial fever.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 41 TRAPS with AA were studied: three new patients and 38 cases from the literature. AA diagnosis preceded that of TRAPS in 96% of cases, and 17\/36 (47%) required renal replacement therapy. Death occurred in 5\/36 (14%) with a median follow-up of 23\u2009months. Effect of biologics on AA were available for 21 regimens in 19 patients: 10 improved renal function, seven stabilized and four worsened. Four patients (36% of transplanted patients) relapse AA on kidney graft (only one under etanercept).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>TRAPS is revealed by AA in most cases. Therefore, clinical features of TRAPS should be screened for in AA patients. IL-1 antagonist can help to normalize inflammation and to preserve renal function.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab252","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T20:10:50Z","timestamp":1615579850000},"page":"5775-5784","source":"Crossref","is-referenced-by-count":22,"title":["Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8492-4248","authenticated-orcid":false,"given":"J\u00e9r\u00e9mie","family":"Delaleu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, APHP, Tenon Hospital, Sorbonne University, GRC GRAASU, Paris, France"},{"name":"National Reference Center for Autoinflammatory Diseases and Inflammatory Amyloidosis (CeR\u00e9MAIA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8887-3233","authenticated-orcid":false,"given":"Samuel","family":"Deshayes","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Normandie University, CHU de Caen Normandie, Caen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, APHP, Tenon Hospital, Sorbonne University, GRC GRAASU, Paris, France"},{"name":"National Reference Center for Autoinflammatory Diseases and Inflammatory Amyloidosis (CeR\u00e9MAIA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Savey","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, APHP, Tenon Hospital, Sorbonne University, GRC GRAASU, Paris, France"},{"name":"National Reference Center for Autoinflammatory Diseases and Inflammatory Amyloidosis (CeR\u00e9MAIA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Rivi\u00e8re","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU de Bordeaux, Haut-L\u00e9v\u00eaque Hospital, Pessac"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas Martin","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Normandie University, CHU de Caen Normandie, Caen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Aouba","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Normandie University, CHU de Caen Normandie, Caen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Amselem","sequence":"additional","affiliation":[{"name":"National Reference Center for Autoinflammatory Diseases and Inflammatory Amyloidosis (CeR\u00e9MAIA)"},{"name":"Genetic Laboratory, Sorbonne University, APHP, Trousseau Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Rabant","sequence":"additional","affiliation":[{"name":"Department of Pathology, APHP, Necker Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Grateau","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, APHP, Tenon Hospital, Sorbonne University, GRC GRAASU, Paris, France"},{"name":"National Reference Center for Autoinflammatory Diseases and Inflammatory Amyloidosis (CeR\u00e9MAIA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Giurgea","sequence":"additional","affiliation":[{"name":"National Reference Center for Autoinflammatory Diseases and Inflammatory Amyloidosis (CeR\u00e9MAIA)"},{"name":"Genetic Laboratory, Sorbonne University, APHP, Trousseau Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6668-8854","authenticated-orcid":false,"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, APHP, Tenon Hospital, Sorbonne University, GRC GRAASU, Paris, France"},{"name":"National Reference Center for Autoinflammatory Diseases and Inflammatory Amyloidosis (CeR\u00e9MAIA)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,14]]},"reference":[{"key":"2021121823180907600_keab252-B1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"2021121823180907600_keab252-B2","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/annrheumdis-2013-204184","article-title":"The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry","volume":"73","author":"Lachmann","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021121823180907600_keab252-B3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/art.37827","article-title":"AA amyloidosis complicating the hereditary periodic fever syndromes","volume":"65","author":"Lane","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021121823180907600_keab252-B4","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/ard.2005.048611","article-title":"Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene","volume":"65","author":"Ravet","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2021121823180907600_keab252-B5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM200010053431412","article-title":"Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome","volume":"343","author":"Drewe","year":"2000","journal-title":"N Engl J Med"},{"key":"2021121823180907600_keab252-B6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9343(00)00716-6","article-title":"Familial periodic fever and amyloidosis due to a new mutation in the TNFRSF1A gene","volume":"110","author":"Simon","year":"2001","journal-title":"Am J Med"},{"key":"2021121823180907600_keab252-B7","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/art.10429","article-title":"The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome","volume":"46","author":"Dod\u00e9","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2021121823180907600_keab252-B8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","article-title":"The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder","volume":"81","author":"Hull","year":"2002","journal-title":"Medicine"},{"key":"2021121823180907600_keab252-B9","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1046\/j.1523-1755.2001.0590051677.x","article-title":"Autosomal-dominant periodic fever with AA amyloidosis: novel mutation in tumor necrosis factor receptor 1 gene Rapid Communication","volume":"59","author":"Jadoul","year":"2001","journal-title":"Kidney Int"},{"key":"2021121823180907600_keab252-B10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ajmg.a.30058","article-title":"A novel mutation of tumor necrosis factor receptor alpha type 1 associated with TRAPS and amyloidosis","volume":"128A","author":"Broeders","year":"2004","journal-title":"Am J Med Genet A"},{"key":"2021121823180907600_keab252-B11","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/rheumatology\/keh357","article-title":"Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome","volume":"43","author":"Drewe","year":"2004","journal-title":"Rheumatology"},{"key":"2021121823180907600_keab252-B12","first-page":"2519","article-title":"Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis","volume":"31","author":"Kallinich","year":"2004","journal-title":"J Rheumatol"},{"key":"2021121823180907600_keab252-B13","first-page":"626","article-title":"Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family","volume":"18","author":"Dinc","year":"2005","journal-title":"J Nephrol"},{"key":"2021121823180907600_keab252-B14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/art.21657","article-title":"Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications","volume":"54","author":"D'Osualdo","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021121823180907600_keab252-B15","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/ard.2005.043570","article-title":"\u201cPeriodic fever\u201d without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis","volume":"65","author":"Kallinich","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2021121823180907600_keab252-B16","first-page":"119","article-title":"No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy","volume":"23","author":"Simsek","year":"2010","journal-title":"J Nephrol"},{"key":"2021121823180907600_keab252-B17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/s10165-010-0273-y","article-title":"Variable intrafamilial expressivity of the rare tumor necrosis factor-receptor associated periodic syndrome-associated mutation I170N that affects the TNFR1A cleavage site","volume":"20","author":"Lehmann","year":"2010","journal-title":"Mod Rheumatol"},{"key":"2021121823180907600_keab252-B18","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/ard.2010.143438","article-title":"Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis","volume":"70","author":"Obici","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021121823180907600_keab252-B19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13075-015-0604-7","article-title":"The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-\u03baB pathway","volume":"17","author":"Greco","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2021121823180907600_keab252-B20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1515\/folmed-2016-0025","article-title":"First Case of TNF-Receptor-Associated Autoinflammatory Syndrome (TRAPS) in Bulgaria","volume":"58","author":"Solakov","year":"2016","journal-title":"Folia Med (Plovdiv)"},{"key":"2021121823180907600_keab252-B21","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s10067-017-3688-4","article-title":"Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature","volume":"36","author":"Gentileschi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2021121823180907600_keab252-B22","first-page":"6819476","article-title":"Treating TNF receptor associated periodic fever syndrome in end-stage renal failure","volume":"2019","author":"Coutinho","year":"2019","journal-title":"Case Rep Nephrol"},{"key":"2021121823180907600_keab252-B23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3390\/jcm10030465","article-title":"Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) with a new pathogenic variant in TNFRSF1A gene in a family of the adult male with renal AA amyloidosis-diagnostic and therapeutic challenge for clinicians","volume":"10","author":"Zegarska","year":"2021","journal-title":"J Clin Med"},{"key":"2021121823180907600_keab252-B24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","article-title":"The TNF and TNF receptor superfamilies: integrating mammalian biology","volume":"104","author":"Locksley","year":"2001","journal-title":"Cell"},{"key":"2021121823180907600_keab252-B25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13023-017-0720-3","article-title":"A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry","volume":"12","author":"Papa","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"2021121823180907600_keab252-B26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.revmed.2018.02.002","article-title":"[Tumor necrosis receptor associated periodic syndrome (TRAPS): state of the art]","volume":"39","author":"Georgin-Lavialle","year":"2018","journal-title":"Rev Med Interne"},{"key":"2021121823180907600_keab252-B27","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases","volume":"74","author":"ter Haar","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021121823180907600_keab252-B28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/rheumatology\/ket400","article-title":"Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study","volume":"53","author":"Kasifoglu","year":"2014","journal-title":"Rheumatology"},{"key":"2021121823180907600_keab252-B29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.autrev.2012.07.020","article-title":"Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives","volume":"12","author":"Cantarini","year":"2012","journal-title":"Autoimmun Rev"},{"key":"2021121823180907600_keab252-B30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Classification criteria for autoinflammatory recurrent fevers","volume":"78","author":"Gattorno","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021121823180907600_keab252-B31","article-title":"Periodic fever syndrome associated with mutations in the TNF type 1 receptor gene: a differential diagnosis of familial Mediterranean fever that should not be overlooked in patients of Mediterranean origin","author":"Bourguiba","year":"2020","journal-title":"Rev Med Interne"},{"key":"2021121823180907600_keab252-B32","doi-asserted-by":"crossref","first-page":"102763","DOI":"10.1016\/j.autrev.2021.102763","article-title":"Interleukin 1\u03b1: a comprehensive review on the role of IL-1\u03b1 in the pathogenesis and treatment of autoimmune and inflammatory diseases","volume":"20","author":"Cavalli","year":"2021","journal-title":"Autoimmun Rev"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab252\/37110370\/keab252.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/12\/5775\/41820372\/keab252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/12\/5775\/41820372\/keab252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T23:26:32Z","timestamp":1639869992000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/12\/5775\/6170651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,14]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,3,14]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab252","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,3,14]]}}}